Key result
Cardiac rehabilitation programs document reductions in mortality and improvements in clinical outcomes beyond revascularization and pharmacotherapy, though they remain under-utilized.
Why the study?
Do cardiac rehabilitation programs improve clinical outcomes and reduce mortality in patients with coronary heart disease?
Do cardiac rehabilitation programs improve clinical outcomes and reduce mortality in patients with coronary heart disease?
Cardiac rehabilitation provides additional mortality and morbidity benefits beyond revascularization and pharmacotherapy for coronary heart disease, highlighting the need to address its under-utilization.
Answers are grounded in this paper and cite their sources.
Supports expanded cardiac rehabilitation referral in coronary disease; leaves open optimal strategies to improve utilization and adherence.
Coronary heart disease is the major cause of death in most industrialized countries and is increasing rapidly in many developing nations. Cardiac rehabilitation programs have evolved from predominantly exercise-based programs into comprehensive secondary prevention programs. Studies of efficacy and effectiveness of cardiac rehabilitation document reductions in mortality and improvements in clinical and behavioral outcomes beyond the improvements in morbidity and mortality already available through revascularization and effective pharmacotherapy, but cardiac rehabilitation, like many preventive measures, is under-utilized. Future research directions are outlined.
No takes yet. Share an insight, caveat, or question.
Bittner et al. (2006) conducted a review in Coronary heart disease. Cardiac rehabilitation was evaluated. Cardiac rehabilitation programs document reductions in mortality and improvements in clinical outcomes beyond revascularization and pharmacotherapy, though they remain under-utilized.
Synapse has enriched 10 related papers. Consider them for comparative context: